Onxeo

Onxeo's email is contact@onxeo.com and Onxeo's phone number is 330145587600 .

Onxeo is a biotechnology company that develops drugs for oncology. It offers Beleodaq, a histone deactylase inhibitor for the treatment of peripheral T-cell lymphoma; Livatag, a nanoparticle formulation of doxorubicin, which is in Phase III clinical trials for the treatment of primary liver cancer; Validive, a mucoadhesive buccal tablet that is in Phase II clinical trials for the prevention and the treatment of chemoradioation therapy-induced severe oral mucositis in patients with head and neck cancer; and Combo BelCHOP, which is Phase II clinical trials for the treatmen...

read more

Onxeo is a biotechnology company that develops drugs for oncology. It offers Beleodaq, a histone deactylase inhibitor for the treatment of peripheral T-cell lymphoma; Livatag, a nanoparticle formulation of doxorubicin, which is in Phase III clinical trials for the treatment of primary liver cancer; Validive, a mucoadhesive buccal tablet that is in Phase II clinical trials for the prevention and the treatment of chemoradioation therapy-induced severe oral mucositis in patients with head and neck cancer; and Combo BelCHOP, which is Phase II clinical trials for the treatment of peripheral T-cell lymphoma. Onxeo is headquartered in Paris, France.

show less

View Top Employees for Onxeo
img Industry Research
img Location Paris, île De France, France
img Employees 2
img HQ 49 Boulevard du Général Martial Valin
img Phone 33014-558-7600
img Email contact@onxeo.com
img Funding 60,395,000 EUR
img Competitors Thermo Fisher Scienti..., National Institutes O..., Pra Health Sciences, Cnrs, Cea Commissariat à ..., Chinese Academy Of Sc..., University Of Souther..., University, Ucsf,
img Industry Research
img Location Paris, île De France, France
img Employees 2
img LinkedIn linkedin.com/company/onxeo
img HQ 49 Boulevard du Général Martial Valin
img Phone 33014-558-7600
img Email contact@onxeo.com
img Funding 60,395,000 EUR